2-113499356-G-A
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_012184.5(FOXD4L1):c.100G>A(p.Glu34Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000112 in 1,610,546 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_012184.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000199 AC: 3AN: 150868Hom.: 0 Cov.: 30
GnomAD3 exomes AF: 0.0000323 AC: 8AN: 247356Hom.: 1 AF XY: 0.0000298 AC XY: 4AN XY: 134246
GnomAD4 exome AF: 0.0000103 AC: 15AN: 1459558Hom.: 0 Cov.: 34 AF XY: 0.00000689 AC XY: 5AN XY: 726078
GnomAD4 genome AF: 0.0000199 AC: 3AN: 150988Hom.: 0 Cov.: 30 AF XY: 0.0000407 AC XY: 3AN XY: 73686
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.100G>A (p.E34K) alteration is located in exon 1 (coding exon 1) of the FOXD4L1 gene. This alteration results from a G to A substitution at nucleotide position 100, causing the glutamic acid (E) at amino acid position 34 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at